In patients with SCN due to ELANE and HAX1 mutations, insufficient activation of NAMPT by GM-CSF, but marked elevation by G-CSF was observed and was suggested to account for the lacking treatment response to GM-CSF in these patients (30). This evidence concerns the gene CSF2 and severe congenital neutropenia.